Unknown

Dataset Information

0

Frequency and Clinical Aspects of Neurological and Psychiatric Symptoms in Patients with Non-Celiac Wheat Sensitivity.


ABSTRACT: Non-Celiac Wheat Sensitivity (NCWS) is characterized by both intestinal and extra-intestinal symptoms. The study aims to investigate the frequency of neuropsychiatric manifestations in NCWS patients and identify their clinical and demographic characteristics. 278 clinical records of NCWS patients, diagnosed by a double-blind placebo-controlled wheat challenge between 2006 and 2020, were retrospectively revised. Fifty-two patients with Celiac Disease (CD) and 54 patients with Irritable Bowel Syndrome (IBS) served as controls. 87% of the NCWS patients had an IBS-like clinical presentation. The NCWS group showed a longer duration of symptoms, a higher frequency of positive serum anti-nuclear antibodies than CD and IBS patients, and a higher frequency of DQ2/DQ8 haplotypes and duodenal mucosa lymphocytosis than IBS controls. In addition, 50% of NCWS patients showed neuropsychiatric manifestations, while lower percentages were observed in CD (25%) and IBS (28%) controls. Neuropsychiatric symptoms in NCWS were more frequently associated with the male sex, longer duration of symptoms, and IBS-diarrhea-like clinical presentation. Our data suggest that in patients with IBS-like symptoms and neuropsychiatric manifestations of unknown cause, it could be useful to investigate a correlation of these symptoms with wheat ingestion to identify NCWS patients with this 'atypical' manifestation.

SUBMITTER: Carroccio A 

PROVIDER: S-EPMC8227001 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Non-Celiac Wheat Sensitivity (NCWS) is characterized by both intestinal and extra-intestinal symptoms. The study aims to investigate the frequency of neuropsychiatric manifestations in NCWS patients and identify their clinical and demographic characteristics.<h4>Methods</h4>278 clinical records of NCWS patients, diagnosed by a double-blind placebo-controlled wheat challenge between 2006 and 2020, were retrospectively revised. Fifty-two patients with Celiac Disease (CD) and 54  ...[more]

Similar Datasets

| S-EPMC5677194 | biostudies-other
| S-EPMC7506149 | biostudies-literature
| S-EPMC5537885 | biostudies-literature
| S-EPMC9319925 | biostudies-literature
| S-EPMC8070191 | biostudies-literature
| S-EPMC9554215 | biostudies-literature
| S-EPMC11364563 | biostudies-literature
| S-EPMC5331534 | biostudies-literature
| S-EPMC7139384 | biostudies-literature
| S-EPMC4586563 | biostudies-literature